MARLVEL

Medisafe Carezone: PillMemo vs its rivals

Side-by-side comparison against Medisafe Carezone: PillMemo's closest competitors — identity, store metrics, ratings & sentiment, and strategic intel.

Medisafe Carezone: PillMemo
This App
NimbleRx
Nemesis
Blood Sugar Glucose Tracker
Contender
WellView
Contender
Gout Diet - Acid Uric Table
Contender
GLP 1 Tracker - Within Reach
Contender
Hickey’s Pharmacy App
Peer
Dose Medbox
Peer
Luka – Blood Glucose Readings
Peer
GotCGM
Peer
Core Identity
DeveloperMarcin JedrzejakNimbleRx199 Developments Private LimitedWellDyneRxngo phongCoreBits LLCHickey’s PharmacyDose MedboxPitou Technologies, LLCGluroo Imaginations Inc.
CategoryMedicalMedicalMedicalMedicalHealth & FitnessHealth & FitnessMedicalMedicalMedicalHealth & Fitness
PlatformiOSiOS, AndroidiOSiOS, AndroidiOSiOSiOS, AndroidAndroid, iOSiOSiOS, Android
Store Metrics
Rating4.9 / 54.9 / 54.6 / 52.9 / 54.4 / 54.8 / 50.0 / 54.8 / 54.6 / 53.9 / 5
Ratings Count1298,085100504212040268
PriceFreeFreeFreeFreeFreeFreeFreeFreeFreeFree
Release DateApr 24, 2024Nov 11, 2015Oct 29, 2024Jul 1, 2020Nov 13, 2020Jan 26, 2026Aug 24, 2018Sep 2, 2018May 12, 2024Jan 22, 2026
Last UpdatedSep 4, 2025Apr 16, 2026May 12, 2026Jun 1, 2026May 8, 2026Feb 16, 2026Apr 14, 2026May 12, 2026Apr 21, 2026Apr 20, 2026
Sentiment & Reviews
Sentiment-positive-mixed-excellent----
Score-75/100-50/100-90/100----
Praises-
  • Automated prescription refills and home delivery services provide significant convenience for daily medication management
-
  • Utility of pharmacy locator and cost-saving tools
-
  • Accountability features like daily check-in reminders help users maintain their health and exercise goals
  • Health data tracking capabilities provide users with a clear view of their personal progress
----
Complaints-
  • Inconsistent prescription visibility and inaccurate refill availability dates frustrate users attempting to manage medication
-
  • Navigation friction and lack of modern health-tracking features
------
Requests-
  • Comprehensive prescription history and vaccination data display requested to improve medication management clarity
---
  • Expanded health tracking metrics for specific conditions like insulin resistance and dosage management
----
Strategic Intel
Strengths
  • Secure health-sharing mechanism enables caregiver-patient collaboration
  • Inventory management feature reduces medication gaps for chronic users
  • B2B pharmacy partnership model drives fulfillment volume
  • Integrated delivery service reduces retail friction
  • Encrypted data storage establishes regulatory trust
-
  • Enterprise-grade access to claims data
  • Direct pharmacy benefit management integration
-
  • Local-first storage architecture creates a privacy-based moat
  • Siri integration lowers logging friction for daily users
  • Apple Health bi-directional sync ensures data portability
----
Weaknesses
  • Free tier limited to one medication entry
  • No offline-first data synchronization mentioned
  • Account authentication failures persist post-update
  • Inconsistent prescription data visibility
  • Lack of HSA payment support
-
  • 0.7★ Android-iOS rating gap
  • No wearable integration
  • Outdated UI navigation
-
  • Zero-revenue model limits long-term sustainability
  • Limited tracking metrics for comorbid conditions
  • Small review volume restricts social proof
----
Pricingfreemiumfreefreemiumfreefreefreefreefreefreefree
MomentumZombieIntenseIntenseMaintenance-ActiveActiveIntense--
Update Cadence1 versions5 versions5 versions2 versions, ~4d avg-3 versions5 versions5 versions--

Compare Medisafe Carezone: PillMemo head-to-head

Disclosure: Independent intel to help mobile builders succeed.

AI-powered analysis with editorial review, built from publicly available sources. Marlvel.ai is not affiliated with, endorsed by, or sponsored by Medisafe Carezone: PillMemo, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

See methodologyContact support

Data licensed under CC-BY-NC 4.0